Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
Authors
Keywords
-
Journal
Diagnostics
Volume 12, Issue 2, Pages 263
Publisher
MDPI AG
Online
2022-01-21
DOI
10.3390/diagnostics12020263
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics
- (2020) B. Afsar et al. Clinical & Translational Oncology
- Intriguing relationship between antihypertensive therapy and cancer
- (2019) Marijana Tadic et al. PHARMACOLOGICAL RESEARCH
- Evaluating large-scale propensity score performance through real-world and synthetic data experiments
- (2018) Yuxi Tian et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies
- (2018) Liang Cao et al. BMC Urology
- The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival
- (2017) Taejong Song et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014
- (2017) Chanu Rhee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies
- (2017) Haibo Ni et al. Oncotarget
- The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study
- (2016) Inés Gómez-Acebo et al. PLoS One
- Use of antihypertensive drugs and risk of skin cancer
- (2015) S.A.J. Schmidt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk
- (2011) Ilke Sipahi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Role of renin-angiotensin system in gastric oncogenesis
- (2011) Mitsushige Sugimoto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells
- (2010) Qiaoke Gong et al. PANCREAS
- Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
- (2009) Kashif Hanif et al. HYPERTENSION RESEARCH
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now